APOE epsilon 4 favours vascular over parenchymal deposition of A beta protein in Alzheimer's disease von Chalmers, K, Wilcock, G, Love, S

Neurofibrillary tangles interfere with transduction of TGF-beta signalling by neurons von Chalmers, K, Wilcock, G, Love, S

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. von Chalmers, K, Wilcock, G, Love, S

Contributors to white matter damage in Alzheimer's disease von Chalmers, K, Wilcock, G, Love, S

Contributors to white matter damage in the frontal lobe in Alzheimer's disease. von Chalmers, K, Wilcock, G, Love, S

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. von Williams, S, Chalmers, K, Wilcock, G, Love, S

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease von Williams, S, Chalmers, K, Wilcock, G, Love, S

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease von Chalmers, K, Zhang, Y, Love, S, Wilcock, G, Kehoe, P

Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies von Chalmers, K, Wilcock, G, Vinters, H, Perry, E, Ballard, C, Love, S

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. von Chalmers, K, Culpan, D, Kehoe, P, Wilcock, G, Hughes, A, Love, S

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. von Miners, J, Van Helmond, Z, Chalmers, K, Wilcock, G, Love, S, Kehoe, P

Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy von Miners, J, van Helmond, Z, Chalmers, K, Wilcock, G, Love, S, Kehoe, P

A new kind of spatial inattention associated with chronic limb pain? von Reid, E, Wallwork, S, Harvie, D, Chalmers, K, Gallace, A, Spence, C, Moseley, G

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. von Chalmers, K, Wilcock, G, Vinters, H, Perry, E, Perry, R, Ballard, C, Love, S

Spatially-defined motor deficits in people with unilateral complex regional pain syndrome von Reid, E, Braithwaite, F, Wallwork, S, Harvie, D, Chalmers, K, Spence, C, Gallace, A, Moseley, G

Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease. von van Helmond, Z, Miners, J, Bednall, E, Chalmers, K, Zhang, Y, Wilcock, G, Love, S, Kehoe, P

Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. von Ballard, C, Chalmers, K, Todd, C, McKeith, I, O'Brien, J, Wilcock, G, Love, S, Perry, E

Key methodological issues for the design and delivery of placebo controlled randomised trials of invasive procedures, including surgery: A systematic review von Cousins, S, Tsang, C, Blencowe, N, Lorenc, A, Chalmers, K, Carr, A, Campbell, M, Cook, J, Beard, D, Blazeby, J

Optimising the design and delivery of placebo surgical interventions in randomised controlled trials: The DITTO framework von Cousins, S, Tsang, C, Blencowe, N, Chalmers, K, Mardanpour, A, Carr, A, Campbell, M, Cook, J, Beard, D, Blazeby, J

Optimizing the design of invasive placebo interventions in randomized controlled trials von Cousins, S, Blencowe, NS, Tsang, C, Chalmers, K, Mardanpour, A, Carr, AJ, Campbell, MK, Cook, JA, Beard, DJ, Blazeby, JM